Lynas plunges on $83m raising

Original article by Sarah-Jane Tasker
The Australian – Page: 19 : 30-Sep-14

The stock of Australian-listed rare earths mining group Lynas Corporation on 29 September 2014 closed 25.22% lower at $A0.086. Investors reacted negatively to news that the company was staging a share issue designed to source $A83m in fresh capital, after posting a 2013-14 loss of $A13.1m. The issue price for the shares will be $A0.08. New institutional stockholders are set to account for $A12m, which Lynas will allocate to servicing of its current liabilities

CORPORATES
LYNAS CORPORATION LIMITED – ASX LYC, SOJITZ CORPORATION, JAPAN OIL GAS AND METALS NATIONAL CORPORATION

Medibank may deliver $5.7b at sale

Original article by Jessica Gardner
The Australian Financial Review – Page: 4 : 30-Sep-14

Analysts have previously valued Medibank Private at between $A4bn and $A4.5bn. Goldman Sachs has suggested that the health insurer could potentially be worth between $A4.1bn and $A5.7bn, while Deutsche Bank values it at $A4.2bn to $A5.3bn. Watermark Funds Management’s Omkar Joshi says the Australian Government is likely to place a lower valuation on the stock in the hope that it will rise on the first day of trading on the sharemarket

CORPORATES
MEDIBANK PRIVATE LIMITED, GOLDMAN SACHS AND PARTNERS AUSTRALIA PTY LTD, DEUTSCHE BANK AG, WATERMARK FUNDS MANAGEMENT PTY LTD, AUSTRALIA. DEPT OF FINANCE, MACQUARIE CAPITAL PTY LTD, NIB HOLDINGS LIMITED – ASX NHF, STANDARD AND POOR’S ASX 200 INDEX, RAMSAY HEALTH CARE LIMITED – ASX RHC, HEALTHSCOPE LIMITED – ASX HSO

Medibank flags cost cuts after float

Original article by Jessica Gardner, Georgia Wilkins
The Australian Financial Review – Page: 1 & 6 : 29-Sep-14

Retail investors can pre-register for the upcoming sharemarket float of Medibank Private, which is expected to be Australia’s largest IPO since QR National in 2010. The Federal Government has indicated that Medibank customers who pre-register will be given priority when shares are allocated in the IPO, although they will not be given any free shares in the health insurer. Meanwhile, Medibank CEO George Savvides says the health fund will seek to reduce costs following the IPO

CORPORATES
MEDIBANK PRIVATE LIMITED, AUSTRALIA. DEPT OF FINANCE, AMP LIMITED – ASX AMP, NIB HOLDINGS LIMITED – ASX NHF, NRMA LIMITED, INSURANCE AUSTRALIA GROUP LIMITED – ASX IAG, AURIZON HOLDINGS LIMITED – ASX AZJ, TELSTRA CORPORATION LIMITED – ASX TLS, MORNINGSTAR PTY LTD, COMMUNITY AND PUBLIC SECTOR UNION

Scales tipped in favour of $400m Huon IPO

Original article by Bridget Carter
The Australian – Page: 18 : 29-Sep-14

Huon Aquaculture, which has a share of 40% of the salmon market in Australia, is staging an IPO worth more than $A400m. Simon Marais, MD of fund management firm Allan Gray Australia, notes that with Tassal commanding 50% the industry is a virtual duopoly, and this will underpin good earnings prospects for Huon. However there are some doubts by others, based on the long maturation period of three years for salmon stocks. Also planning a float is jewellery company Lovisa

CORPORATES
TASSAL GROUP LIMITED – ASX TGR, HUON AQUACULTURE COMPANY PTY LTD, LOVISA PTY LTD, ALLAN GRAY AUSTRALIA PTY LTD, PETUNA AQUACULTURE PTY LTD, CREDIT SUISSE (AUSTRALIA) LIMITED, CIMB SECURITIES INTERNATIONAL (AUSTRALIA) PTY LTD, MORGANS FINANCIAL LIMITED

Skin cancer drug developer plans to list

Original article by Sally Rose
The Australian Financial Review – Page: 19 : 29-Sep-14

Melbourne-based Ascend Biopharmaceuticals will offer its shares at $A0.35 in an IPO that aims to raise between $A9m and $A11m. Proceeds of the float will be used to finance clinical trials of drugs that are intended to treat skin cancer and breast cancer. Ascend shares are slated to list on the Australian sharemarket on 14 November 2014

CORPORATES
ASCEND BIOPHARMACEUTICALS LIMITED, ONYVAX, ALCHEMIA LIMITED – ASX ACL, AMRAD CORP LIMITED, F HOFFMAN-LA ROCHE LIMITED, F HOFFMAN-LA ROCHE AG, IMMATICS, LODGE CORPORATE PTY LTD, TRANSGENE

Sydney’s financial dreams fall flat as Asian cities climb ranks

Original article by James Eyers
The Australian Financial Review – Page: 17 : 26-Sep-14

The importance of Sydney as an international financial centre is diminishing, while big Asian cities are becoming more important. The Global Financial Centres Index, published by the Z/Yen Group, ranks Sydney 23th and Melbourne 24th. Sydney was ranked ninth in 2007. More must be done to strengthen the Australian funds management industry. The Financial Services Council supports the introduction of an investment manager regime which offers tax incentives to foreign investors

CORPORATES
FINANCIAL SERVICES COUNCIL, Z/YEN GROUP LIMITED

Medibank Private’s $4bn float is given a clean bill of health

Original article by Michael Bennet
The Australian – Page: 21 : 26-Sep-14

Morningstar is upbeat about Australia’s private health insurance sector, and believes that Medibank Private has scope to increase its margins and profits as a listed company. The independent research firm says investors should pre-register for the Medibank prospectus. Brokers will begin marketing the $A4bn-plus IPO to fund managers in late September 2014

CORPORATES
MEDIBANK PRIVATE LIMITED, MORNINGSTAR PTY LTD, BUPA AUSTRALIA PTY LTD, NIB HOLDINGS LIMITED – ASX NHF, HOSPITAL BENEFIT FUND OF WA INCORPORATED, HBF HEALTHFUNDS INCORPORATED, MACQUARIE GROUP LIMITED – ASX MQG, GOLDMAN SACHS AND PARTNERS AUSTRALIA PTY LTD, DEUTSCHE BANK AG

Investors ‘too bold’

Original article by Max Mason
The Australian Financial Review – Page: 33 : 25-Sep-14

Financial markets anticipate that Australian companies will achieve eight per cent growth in earnings per share in 2014-15. However, Matt Sherwood of Perpetual believes that this may be too optimistic, noting that the economy is forecast to expand by just 4-5 per cent. Meanwhile, BT Investment Management is bullish about Australian shares, and expects stocks to deliver an annual return of 10 per cent over five years

CORPORATES
PERPETUAL LIMITED – ASX PPT, BT INVESTMENT MANAGEMENT LIMITED – ASX BTT, DELTEC INTERNATIONAL GROUP, RESERVE BANK OF AUSTRALIA

Fears of GFC-style complacency

Original article by Richard Gluyas, Michael Bennet, Annabel Hepworth
The Australian – Page: 20 : 23-Sep-14

An Australian fund manager has raised concerns about the state of financial markets. Dion Hershan, of Goldman Sachs Asset Management, said that markets are becoming similar to markets in 2006 before the global financial crisis. He said that credit spreads are tight, companies are using financial engineering and many have high growth and valuation expectations. Hershan said that rising global interest rates and declining commodity prices have made investors worried about a correction

CORPORATES
GOLDMAN SACHS ASSET MANAGEMENT, NATIONAL AUSTRALIA BANK LIMITED – ASX NAB, WESTPAC BANKING CORPORATION – ASX WBC, AUSTRALIA AND NEW ZEALAND BANKING GROUP LIMITED – ASX ANZ, COMMONWEALTH BANK OF AUSTRALIA – ASX CBA, STANDARD AND POOR’S ASX 200 INDEX, RIO TINTO LIMITED – ASX RIO, BHP BILLITON LIMITED – ASX BHP, UBS HOLDINGS PTY LTD, GROUP OF TWENTY (G-20), AUSTRALIAN BANKERS’ ASSOCIATION

Funds cash up for expansion

Original article by Ben Wilmot
The Australian – Page: 30 : 23-Sep-14

Real estate investment trusts are raising capital for expansion. South African-listed Investec Australia Property Fund plans to raise $A120 million. It is buying a $A65.5 million office tower in central Brisbane. GPT Metro Office Fund aims to raise $A255 million in a bookbuild on 30 September 2014

CORPORATES
INVESTEC AUSTRALIA PROPERTY FUND, GPT METRO OFFICE FUND, GPT GROUP – ASX GPT, MORGANS FINANCIAL LIMITED, NATIONAL AUSTRALIA BANK LIMITED – ASX NAB, LION PTY LTD, KIRIN HOLDINGS COMPANY LIMITED, SAMSUNG (AUSTRALIA) PTY LTD, FIFE CAPITAL PTY LTD, IM MEDICAL LIMITED – ASX IMI, ADX MANAGEMENT LIMITED, FAIRFAX MEDIA LIMITED – ASX FXJ